Nek11 activators belong to a distinctive chemical class characterized by their ability to modulate the activity of Nek11, a member of the NIMA (never in mitosis A) related kinase family. Nek11, also known as serine/threonine-protein kinase 11, plays a pivotal role in regulating cell cycle progression and ensuring genomic stability. This class of compounds acts specifically on Nek11, influencing its enzymatic activity and downstream signaling pathways. The intricate molecular interactions between Nek11 and its activators contribute to the modulation of critical cellular processes, particularly those associated with cell division and DNA damage response.
The structural diversity within the Nek11 activator chemical class is noteworthy, as it encompasses a range of small molecules with distinct chemical scaffolds. These compounds typically engage in intricate binding interactions with specific regions of the Nek11 enzyme, leading to conformational changes that affect its catalytic activity. The mechanistic details underlying Nek11 activation by this chemical class are still an area of active research, and ongoing studies are elucidating the precise binding modes and structural alterations induced by these activators. Understanding the molecular nuances of Nek11 activation provides valuable insights into the fundamental regulatory mechanisms governing cell cycle progression and DNA integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1-Naphthyl PP1 | 221243-82-9 | sc-203765 sc-203765A | 10 mg 50 mg | $235.00 $983.00 | 3 | |
ATP analogue designed to interact with the kinase domain, potentially activating Nek11. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
CDK inhibitor that may indirectly activate Nek11 by promoting cell cycle progression, particularly through CDK1. | ||||||
IPA 3 | 42521-82-4 | sc-204016 sc-204016A | 5 mg 50 mg | $94.00 $458.00 | 6 | |
PAK inhibitor with the potential to indirectly activate Nek11 by modulating the PAK1 pathway. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
Chk inhibitor that could indirectly activate Nek11 by modulating the DNA damage response pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor with the potential to indirectly activate Nek11 by modulating the PI3K/AKT pathway. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
AKT inhibitor affecting the PI3K pathway, potentially activating Nek11 indirectly through this pathway. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor impacting the DNA damage response pathway, potentially indirectly activating Nek11. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
CK1 inhibitor that may indirectly activate Nek11 by modulating the CK1 pathway, with which Nek11 interacts. | ||||||